Understanding Integrating In Vitro Microtissues And In Vivo Endpoints In Drug Discovery Development
If you are looking for information about Integrating In Vitro Microtissues And In Vivo Endpoints In Drug Discovery Development, you have come to the right place. Presented At: Laboratory Animal Sciences Virtual Event 2019 Presented By: Matthew Wagoner, PhD - Associate Director of ...
Key Takeaways about Integrating In Vitro Microtissues And In Vivo Endpoints In Drug Discovery Development
- 1 event of our live webinar series focused on CNS
- Originally aired: March 2022 Presenters: Andrew G. Taylor, Ph.D., Manager of Technical Support for Services at XenoTech and ...
- Daniel Gustafson, PhD.
- Watch the Full Video at ...
- D. Lansing Taylor of the University of Pittsburgh discusses quantitative systems pharmacology and the bridge from in
Detailed Analysis of Integrating In Vitro Microtissues And In Vivo Endpoints In Drug Discovery Development
Kevin Curran Ph.D. describes some of the reasons in In Part 3, we focus on in Marjory Moreau, PhD, Associate Director of Computational Toxicology, explains how to use PBPK Modeling in In
Presentations and a panel consider the utility of in
We hope this detailed breakdown of Integrating In Vitro Microtissues And In Vivo Endpoints In Drug Discovery Development was helpful.
